Discovering a new ADC
After intense research investigations Heidelberg Pharma found a unique access to a fully synthetic route for α-Amanitin. With CARBOGEN AMCIS, Heidelberg Pharma developed a scalable and economical route providing α-Amanitin now available for the development of new therapeutic ADC’s.
A joint effort of CARBOGEN AMCIS and Takeda Pharmaceutical - Dr. G Elena Daia (Process R&D Team Leader) at CARBOGEN AMCIS Ltd.
The following case study is one example of how CARBOGEN AMCIS helps customers to advance their projects with a dedicated team and state-of-the-art techniques.
DynoChem/Chemical Engineering at CARBOGEN AMCIS - Part 1
Article & Case Studies
A case study by Franz Amann - Senior Scientist Development at CARBOGEN AMCIS
Franz Amann about CARBOGEN AMCIS' flow chemistry capabilities.
Learn more about our Development & Aseptic Production of Drug Products services with a dedicated case study.
Learn more about our efficient and effective technology transfer process with a dedicated case study.